Hybio Pharmaceutical (300199) — Cash Flow Reinvestment Rate
Hybio Pharmaceutical (300199) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting CN¥95.60 Million (capex CN¥95.60 Million ) from operating cash flow of CN¥117.78 Million. See 300199 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hybio Pharmaceutical Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Hybio Pharmaceutical across 17 annual periods. For the full cash flow conversion analysis, see 300199 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hybio Pharmaceutical (2007–2024)
Year-by-year capital reinvestment analysis for Hybio Pharmaceutical. See 300199 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥116.14 Million | CN¥164.71 Million | CN¥115.84 Million | ▼ -97.1% |
| 2022 | 24.36x | CN¥385.14 Million | CN¥15.81 Million | CN¥189.85 Million | ▲ +1635.3% |
| 2021 | 1.40x | CN¥220.20 Million | CN¥156.83 Million | CN¥199.00 Million | ▼ -73.9% |
| 2020 | 5.39x | CN¥258.66 Million | CN¥47.99 Million | CN¥243.66 Million | ▼ -7.0% |
| 2019 | 5.80x | CN¥606.40 Million | CN¥104.64 Million | CN¥570.15 Million | ▼ -36.0% |
| 2018 | 9.06x | CN¥425.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▲ +771.3% |
| 2017 | 1.04x | CN¥222.14 Million | CN¥213.74 Million | CN¥221.14 Million | ▲ +133.7% |
| 2016 | 0.44x | CN¥131.80 Million | CN¥296.41 Million | CN¥116.05 Million | ▼ -94.5% |
| 2015 | 8.09x | CN¥1.12 Billion | CN¥138.84 Million | CN¥358.98 Million | ▲ +1358.1% |
| 2014 | 0.56x | CN¥85.16 Million | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥302.85 Million | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥221.38 Million | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥78.27 Million | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥22.83 Million | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥9.01 Million | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥60.28 Million | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥4.90 Million | CN¥49.04 Million | CN¥4.90 Million | — |